newsfilter
← Latest News
PR Newswire·

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

YS

YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company...